Michael B. Hoffman
Founder of Northern Genesis Acquisition Corp., Northern Genesis Acquisition Corp. II, Northern Genesis Acquisition Corp. III and Stone Capital Partners LLC, Michael B. Hoffman is an entrepreneur and businessperson who has been at the head of 5 different companies and currently holds the position of Chairman of Annovis Bio, Inc., President for Northern Genesis Acquisition Corp. II, President for Northern Genesis Acquisition Corp. III and President of Northern Genesis Acquisition Corp. Michael B. Hoffman is also Member-Executive Council at International Institute For Nanotechnology, Partner at Stone Capital Partners LLC and Managing Director at Northern Genesis Climate Solutions Corp. and on the board of 14 other companies.
In the past Michael B. Hoffman occupied the position of Chairman at Onconova Therapeutics, Inc., Partner at Riverstone Holdings LLC and Partner at Riverstone Investment Group LLC (a subsidiary of Riverstone Holdings LLC), Senior Managing Director at The Blackstone Group, Inc. (Illinois), Managing Director & Co-Head-Mergers & Acquisitions at Smith Barney Harris Upham & Co., Inc. and Head-Mergers & Acquisitions at Smith Barney & Co., Inc.
He received a graduate degree and an undergraduate degree from Northwestern University and an MBA from Harvard Business School.
|01/04/2022||90||Derivative/Non-derivative trans. at $19.78 per share.||1,781|
|01/04/2022||7,142||Derivative/Non-derivative trans. at $0.25 per share.||1,785|
|01/04/2022||6,658||Derivative/Non-derivative trans. at $19.78 per share.||131,696|
|01/04/2022||30,000||Derivative/Non-derivative trans. at $4.39 per share.||131,700|
|01/31/2020||55,884||Derivative/Non-derivative trans. at $4.8 per share.||268,243|
|01/31/2020||1,137,942||Derivative/Non-derivative trans. at $0 per share.||0|
|01/31/2020||158,730||Derivative/Non-derivative trans. at $0 per share.||0|
|01/31/2020||33,333||Acquisition at $6 per share.||199,998|